-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

506. Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells: Poster II

Hematopoiesis and Stem Cells: Microenvironment, Cell Adhesion and Stromal Stem Cells Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Malwina Suszynska, PhD1*, Daniel Pedziwiatr, MSc1*, Magdalena J Kucia, PhD1, Mariusz Z Ratajczak, MD, PhD2 and Janina Ratajczak, MD, PhD3

1Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY
2Medicine, Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY
3Stem Cell Institute at the James Graham Brown Cancer Center, University of Louisville, Louisville, KY

Ahmed Abdelbaset-Ismail, PhD1*, Malwina Suszynska, PhD1*, Sylwia Julita Borkowska, PhD2*, Mateusz Adamiak, MS1*, Janina Ratajczak, MD, PhD1 and Mariusz Z Ratajczak, MD, PhD1

1Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY
2Department of Physiology, Pomeranian Medical University, Szczecin, Poland

Dorian Forte, Ph.D. Student1*, Valentina Salvestrini, Ph.D.2*, Lucia Catani, Ph.D.1*, Roberto M Lemoli, Professor3, Michele Cavo4* and Antonio Curti, MD, PhD4*

1Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
2Department of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy
3Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy
4Institute of Hematology, Bologna, Italy

Shabnam Arsiwala, MD, Wei Ding, MD PhD* and Hong-Gang Wang, PhD*

Department of Pediatrics, Penn State Hershey College of Medicine, Hershey, PA

Athanasia Kalyva, PhD1*, Charalampos Pontikoglou, MD, PhD1,2*, Christina Kalpadakis, MD, PhD1*, Athina Trakaki1,3*, Nikitas Zorzos1*, Maria Velegraki, MD, PhD1*, Grigorios Panteloglou1*, Kallliopi Alpantaki, MD, PhD4*, Gerasimos A. Pangalis, MD, PhD5* and Helen A Papadaki, MD, PhD1,2

1Department of Hematology, University of Crete, School of Medicine, Heraklion, Greece
2Hemopoiesis Research Laboratory, University of Crete, School of Medicine, Heraklion, Greece
3Graduate Program Molecular Basis of Human Disease, University of Crete School of Medicine, Heraklion, Greece
4Department of Orthopedics, University of Crete, School of Medicine, Heraklion, Crete, Greece
5Department of Hematology, Iatriko Athinon, Psychikon Branch, Athens, Greece

Hirohito Minami1*, Kohshi Ohishi, MD, PhD2, Masahiro Masuya, MD, PhD1 and Naoyuki Katayama, MD, PhD1

1Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Mie, Japan
2Blood Transfusion Service, Mie University Hospital, Tsu, Mie, Japan

Monika Dolinska1*, Johannis Klang1*, Pingnan Xiao, MD1*, Andranik Durgaryan1*, Lakshmi Sandhow1*, Anne-Sofie Johansson1*, Makoto Kondo1*, Stefan Deneberg, M.D., Ph.D.2*, Johanna Ungerstedt, Associate Professor3*, Katarina Le Blanc, M.D., Ph.D.4, Leif Stenke, MD, PhD5, Marja Ekblom6*, Ulla Stromberg, MD PhD7*, Satu Mustjoki, MD, PhD8, Soren Lehmann, MD, PhD1 and Hong Qian, PhD1*

1Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden
2Center of Hematology, Karolinska University Hospital, Stockholm, Sweden
3Department of Medicine Huddinge, Karolinska Institutet, and Hematology Center, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden
4Laboraroty Medicine/Clinical Immunology, Karolinska Institutet, Stockholm, Sweden
5Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
6Department of Hematology and Vascular Disorders, Skåne University Hospital, Lund, Sweden
7Dept of Hematology, Uppsala University Hospital, Uppsala, Sweden
8Hematology Research Unit Helsinki (HRUH), Department of Hematology, University of Helsinki and Helsinki University Central Hospital Comprehensive Cancer Center, Helsinki, Finland

Dina Bashir AbuSamra, MScs

Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia

Renata Giardini Rosa, PhD1*, Juares E. Romero Bianco, PhD2*, Gabriela Pereira dos Santos2*, Stephen D. Waldman, Ph.D., P.Eng.3*, Joanna Weber, PhD candidate3*, Paulo P. Joazeiro, PhD4* and Sara Teresinha Olalla Saad, PhD, MD2

1Hematology and Hemotherapy Center-University of Campinas/Hemocentro-Unicamp, Instituto Nacional de Ciência e Tecnologia do Sangue, Campinas, Brazil
2Instituto Nacional de Ciência e Tecnologia do Sangue, Unicamp - University of Campinas, Campinas, Brazil
3Department of Mechanical and Materials Engineering/ Li Ka Shing Knowledge Institute, Queen’s University, Kingston, ON, Canada/Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada., Toronto, ON, Canada
4Department of Biochemistry and Tissue Biology – Biology institute, University of Campinas, Campinas, Brazil

Jingzhu Zhang, BS1 and Daniel C. Link, MD2

1Department of Internal Medicine, Division of Oncology, Section of Stem Cell Biology, Washington University School of Medicine, St Louis, MO
2Internal Medicine, Washington University School of Medicine, Saint Louis, MO

Willy A Noort, PhD1*, Regina de Jong-Korlaar1*, Linda Lubbers-Aalders1*, Huipin Yuan, PhD2*, Joost D de Bruijn, PhD2*, Constantine S Mitsiades, MD, PhD3, Anton CM Martens, PhD1* and Richard WJ Groen, PhD1*

1Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
2Xpand Biotechnology BV, Bilthoven, Netherlands
3Dept. of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Venkata Lokesh Battula, PhD1, Phuong M Le1*, Jeffrey Sun, B.S.1*, Hong Mu, MD, PhD1*, Teresa Mc.Queen, M.S.1*, Elizabeth J Shpall, MD2, Marina Konopleva, MD, PhD1, Carlos E. Bueso-Ramos, MD3, Melvyn Harrington, MD4*, Catherine W Palisch, MD4* and Michael Andreeff, MD, PhD1

1Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX
2Department of Stem Cell Transplantation and Cellular Therapy, UT MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
4Baylor College of Medicine, Houston, TX

*signifies non-member of ASH